Talk:Metamucil

Removal of advertising copy

I've removed a few sentences from this article because they appear to be unsubstantiated advertising copy. Specifically:

• It is clinically proven to reduce cholesterol when used as part of a low-fat, low-cholesterol diet. — this statement requires sourcing, and clinically proven is vague and unencylopedic
• Metamucil is the number one doctor and pharmacist recommended fiber supplement/bulk fiber laxative — again this needs sourcing and reads like an ad. Besides, what does "number one" mean? Number one where? Number one by what measure?
• capsules plus calcium — this is poor grammar and since capsules are already listed, the existence of capsules that have calcium in them as well is not particularly notable.

Ben Arnold 09:12, 21 May 2006 (UTC)

The IP that added this content (IP 63.236.225.130) appears to belong to a marketing company in the United States called Delve LLC. Ben Arnold 09:24, 21 May 2006 (UTC)

The whole 'health benefits' section sounds like a fully fledged advert for Metamucil; something needs to be done about that. Jffner (talk) 09:20, 14 January 2010 (UTC)

"Has Been Shown" to "May also"

Changed some wording regarding the lowering of cholesterol, in order to conform to the cited source.— Preceding unsigned comment added by 65.14.17.69 (talk • contribs) 03:55, 7 September 2007‎ (UTC)

More removal of advertising copy

I am a different person than the one below above, but today I removed uncited sentences that were pure advertising copy, and edited the few cited ones to have a more encyclopedic tone. Also changed a few weasel and advertisement-like words around to sound more encyclopedic. The article was also quite redundant, listing unnecessary "potential benefits" listed in the psyllium husk page to sound like an advertisement, like a commercial will list benefits, whereas an encyclopedia lists cited features. —Preceding unsigned comment added by 24.116.111.191 (talk) 10:58, 24 May 2011 (UTC)

"Hindrance on absorption of vitamins & minerals" doesn't seem correct

Under Potential Side Effects it says "...the intake of dietary fiber could hinder the absorption of vitamins, minerals, and proteins". However when I went to the cited reference, it had no mention to a hindrance to vitamins, minerals, nor proteins. In the wiki entry of "Dietary Fiber" under Effects of fiber intake it says "Fiber does not bind to minerals and vitamins and therefore does not restrict their absorption...", the complete opposite. The "Dietary Fiber" entry cites 3 references which I checked out and they do say minerals absorption is not affected by fiber. The "Dietary Fiber" entry does go on to say "Some plant foods can reduce the absorption of minerals and vitamins like calcium, zinc, vitamin C, and magnesium, but this is caused by the presence of phytate (which is also thought to have important health benefits), not by fiber." with one cited reference to that. — Preceding unsigned comment added by BlitzWing00 (talk • contribs) 12:13, 1 April 2012 (UTC)

I read the reference, and I do not support this criticism. Reference 3 has a section headed "Potential negative effects of dietary fibre", and the first sentence under this heading states "Potential negative effects of dietary fibre include reduced absorption of vitamins, minerals, proteins and calories". Surely this is a clear statement which is cited by the Wikipedia article? I think the sentence of the article citing this reference could be better-written, but I find no problem with it on factual grounds. This citation does contain the information to support the article's assertion. The [not in citation] tag should be removed. Marchino61 (talk) 02:35, 17 November 2014 (UTC)

We're Back?

Metamucil is currently advertising "We're Back". Was the product taken off the market and if so, why? — Preceding unsigned comment added by 76.173.136.32 (talk) 19:09, 17 May 2013 (UTC)

< It is also reported to give cleaner feces, allowing for use of less toilet paper. >

Please allow this very personal experience but this sentence is the closest to a very annoying reality I have described to my general practitioner AND specialists for the last 5 years………without any satisfactory answer, understanding or solution until one day, a friend mentioned that Metamucil seemed to work both ways : help with constipation, and help with……the contrary, which, being a sceptic, I did not believe. I confronted a GOOD pharmacist with a 1st bottle in hand, and he confirmed it did work both ways, depending on the amount of water associated (with lots of water against constipation, with 1 glass of water for the adverse situation……). The result is SO obvious, I wish there was a way to let it be known to people having to put up with a difficulty close to, but not the "irritable bowel syndrome", where you need "soluble fibers" but NOT "insoluble fibers" according to readings on the subject for the past 5 years !!!. Meanwhile, allow me to think that pharmaceutical companies surely prefer people to spend a fortune on very expensive pro-biotic supplements. Judith75

Metamucil readded as a standalone page

The current page focuses much more on the brand than on the fiber (as opposed to the previous version). This is a paid contribution.

Adding Metamucil as a standalone page for the brand

This is a proposal for the new page of the Metamucil brand. The previous page focused mainly on the effects of the ingredients and has been folded with psyllium seed husks. This edit contains much more information on the brand itself. This is a paid contribution. The new content of the article can be found below:

Edit request

Metamucil Product type Fibre supplements Owner Procter & Gamble Country United States Introduced 1934 (1934) Markets Worldwide Previous owners G. D. Searle & Company Registered as a trademark in 2005 Website www.metamucil.com/en-us Metamucil is a brand of laxative and fiber supplements. Introduced in 1934 by G. D. Searle & Company, the brand was acquired by Procter & Gamble in 1985. Products Metamucil is sold as powdered drink mixes, capsules, and wafers, in a variety of flavors, including orange, berry, and sugar-free options. Metamucil contains psyllium seed husks as the active ingredient. Metamucil products are manufactured in Phoenix, Arizona, by Procter & Gamble. History Metamucil was introduced by G. D. Searle & Company in 1934 and its name is a combination of the Greek word for change (meta), with the class of fiber it utilizes (mucilage). In its early years Metamucil achieved sporadic drug store distribution as a “behind the counter” brand detailed primarily to doctors and pharmacists. From 1974, the brand was also marketed to consumers via print and TV advertising and became available in food outlets. Orange flavoring was added in 1979. In 1985, Procter & Gamble acquired Metamucil as part of its continuing effort to expand into health care. Marketing When first marketed to consumers in 1974, Metamucil recommended consumers eat the right foods, drink plenty of water, and exercise in order to be regular. In those cases when a consumer needed help, Metamucil advertising pointed out it was made from grain and not a chemical stimulant. The advertising claim at that time was “If not nature, then Metamucil”. Procter & Gamble sought to make Metamucil a household name by advertising in magazines and on television, using the claim “All fiber is not created equal”. In 2018, Metamucil started a new marketing campaign entitled “The Metamucil Two-Week Challenge” which encourages customers to take Metamucil for two weeks in order to promote their digestive health. Intellectual Property Patents for Metamucil are owned by Procter & Gamble in the United States, Canada, Mexico, Spain, Germany, Ireland, Japan, and Australia. The Metamucil trademark is owned by Procter & Gamble and was first approved in 1934. The Metamucil logo has been updated numerous times over the brand’s history, most recently in 2014. References

KrzysztofC (talk) 08:55, 28 April 2020 (UTC)

Reply 02-MAY-2020

  Please use WP:AFC  

• Please submit your request through articles for creation.

Regards,  Spintendo  17:10, 2 May 2020 (UTC)

Stand-Alone Page Discussion

User:KrzysztofC, User:Spintendo, User:Spencer, User:Klbrain, User:Doc James, User:Tom Reding -

Draft:Metamucil was submitted via Articles for Creation. I see that there has previously been an article, and the article has periodically been stubbed down to a redirect. The previous article has history, so that, if there is to be a separate article, the previous article and not a new page should be restored. There must be a community decision to establish rough consensus on whether a separate article for Metamucil is in order in addition to Psyllium. At this point, with the redirect currently in place, the least disruptive approach seems to be a Redirect for Discussion against the current redirect, requesting that the article be restored. If there is no objection to an RFD within 36 hours, I will make a procedural RFD nomination in order to start the process, reserving the right to !vote during the 7 days. Robert McClenon (talk) 16:40, 4 May 2020 (UTC)

For now, I have declined the draft, because accepting the draft would lose history. A rough consensus discussion is needed on whether to have a redirect or a separate article. Robert McClenon (talk) 16:40, 4 May 2020 (UTC)

I'd recommend retaining the redirect, but developing a section for the brand on the Psyllium page, which is small enough to accommodate it, yet large enough that it wouldn't be swamped with tightly-written incoming content. The reason for this is that that product makes a medical claim (laxative) and in general drug brand names have one page under the name of the generic drug. In this case, we have a generic name for a medicine (rather than a drug), and I think that its reasonable that a similar pattern be applied. The style guide on the Pharmacology project (WP:WikiProject Pharmacology/Style guide#Medications) has a specific section for notable brand names. As per WP:PRODUCT, products don't usually have a separate page, although I accept that this is a relatively important and long-lived brand; the alternative target of the article on the company isn't appropriate, as it is too big. Klbrain (talk) 16:58, 4 May 2020 (UTC)

I see two questions, a substantive question and a procedural question. The substantive question is at what level Metamucil should be documented: in a stand-alone article, in the ingredient, Psyllium, or with the company. The procedural question is what means should be used to decide the substantive question. I think that User:Klbrain has made a substantive argument, redirect to a possibly expanded section in Psyllium. The possible answers to the procedural question are: by discussion with consensus; by edit-warring; by a formal process. I think that we can see that there isn't a consensus, so that trying to resolve it by discussion will just mean going on and on. We all know that edit-warring is a malum in se, that is, something bad that is forbidden because it is bad. I think that the appropriate formal process for redirect disputes is normally a deletion discussion, and in this case, with the redirect already in place, that is Redirects for Discussion. So I will make a procedural nomination for RFD, unless someone can persuade me that there is a better way to resolve the issue. Robert McClenon (talk) 20:24, 4 May 2020 (UTC)

A very reasonable procedural decision. Klbrain (talk) 20:26, 4 May 2020 (UTC)

We redirect brands to generics when it comes to medications per WP:MEDMOS/WP:PHARMMOS. The one exception is when a single brand name is used for multiple medications. And probably in that case a disambig would be best.

Once the discussion of brands becomes too large we can split it off into an article like Paracetamol brand names Doc James (talk · contribs · email) 04:32, 5 May 2020 (UTC)

2022 update

For the record, I just happened to look up this topic and stumbled upon this page. Amazingly, someone had just converted it from a redirect to a full article an hour prior. Do people think that the same argument Doc James mentioned above still applies? 98.170.164.88 (talk) 07:03, 2 August 2022 (UTC)